AI Article Synopsis
- Weekly injections for treating growth deficiency in children are just as effective as daily injections, showing similar growth rates.
- The safety of weekly injections is comparable to daily injections, indicating no significant risk differences.
- It's important to note that treatment decisions should consider all evidence, not just one study, and approval for the drug may vary by country.
Article Abstract
• The efficacy of weekly injections was no different from that of daily injections to treat children who don't make enough growth to grow adequately. ○ Efficacy refers to how well a drug works in a clinical trial. ○ Children treated with weekly had an increased growth rate, similar to that of children treated with daily . • The safety of weekly injections was similar to that of daily injections. Efficacy and safety of weekly vs daily in children with growth deficiency: a phase 3 study. 2022; 107(7): e2717-e2728. The purpose of this plain language summary is to help you to understand the findings from recent research. • is used to treat growth deficiency (the condition under study that is discussed in this summary). Approval varies by country; please check with your local healthcare provider for more details. • The results of this study may differ from those of other studies. Physicians/providers should make treatment decisions based on all available evidence and not on the results of a single study.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11544662 | PMC |
| http://dx.doi.org/10.1177/20420188241277404 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!